Overview

A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation

Status:
Recruiting

Trial end date:
2021-08-30

Target enrollment:

Participant gender:

Summary

This is a multi-center, randomized, single-blind, propofol-controlled phase III clinical study. In this study, ICU patients undergoing mechanical ventilation are expected to be enrolled and will be randomly assigned to the HSK3486 group and the propofol group.

Phase:

Phase 3

Details

Lead Sponsor:

Haisco Pharmaceutical Group Co., Ltd.

Treatments:

Propofol